Key points are not available for this paper at this time.
Volunteer participants were able to ambulate with the ReWalk™ for a distance of 100 m, with no adverse effects during the course of an average of 13-14 training sessions. The participants were generally positive regarding the use of the system.
Zeilig et al. (Wed,) studied this question.